A detailed history of Telos Capital Management, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Telos Capital Management, Inc. holds 26,425 shares of NVS stock, worth $2.81 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
26,425
Previous 26,979 2.05%
Holding current value
$2.81 Million
Previous $2.72 Million 6.17%
% of portfolio
0.29%
Previous 0.34%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$95.27 - $108.47 $52,779 - $60,092
-554 Reduced 2.05%
26,425 $2.56 Million
Q4 2023

Jan 30, 2024

BUY
$92.27 - $101.54 $79,352 - $87,324
860 Added 3.29%
26,979 $2.72 Million
Q3 2023

Nov 01, 2023

SELL
$94.73 - $105.13 $43,102 - $47,834
-455 Reduced 1.71%
26,119 $2.66 Million
Q2 2023

Jul 20, 2023

SELL
$92.52 - $104.91 $70,500 - $79,941
-762 Reduced 2.79%
26,574 $2.68 Million
Q1 2023

Apr 27, 2023

BUY
$80.03 - $92.81 $14,965 - $17,355
187 Added 0.69%
27,336 $2.51 Million
Q4 2022

Jan 27, 2023

BUY
$75.55 - $92.52 $204,967 - $251,006
2,713 Added 11.1%
27,149 $0
Q3 2022

Oct 31, 2022

BUY
$74.61 - $87.26 $91,770 - $107,329
1,230 Added 5.3%
24,436 $1.86 Million
Q2 2022

Aug 08, 2022

BUY
$80.52 - $93.75 $57,169 - $66,562
710 Added 3.16%
23,206 $1.96 Million
Q1 2022

May 02, 2022

SELL
$80.11 - $90.62 $17,624 - $19,936
-220 Reduced 0.97%
22,496 $1.97 Million
Q4 2021

Jan 21, 2022

BUY
$79.7 - $88.13 $15,382 - $17,009
193 Added 0.86%
22,716 $1.99 Million
Q3 2021

Oct 19, 2021

SELL
$81.78 - $95.14 $64,197 - $74,684
-785 Reduced 3.37%
22,523 $1.84 Million
Q2 2021

Jul 15, 2021

SELL
$85.24 - $94.15 $2.23 Million - $2.46 Million
-26,128 Reduced 52.85%
23,308 $2.13 Million
Q1 2021

Apr 28, 2021

BUY
$83.5 - $98.47 $36,072 - $42,539
432 Added 0.88%
49,436 $4.23 Million
Q4 2020

Feb 02, 2021

BUY
$78.07 - $94.43 $104,613 - $126,536
1,340 Added 2.81%
49,004 $4.63 Million
Q3 2020

Oct 27, 2020

BUY
$82.14 - $91.0 $75,075 - $83,174
914 Added 1.96%
47,664 $4.15 Million
Q2 2020

Jul 23, 2020

BUY
$80.93 - $91.1 $150,287 - $169,172
1,857 Added 4.14%
46,750 $4.08 Million
Q1 2020

May 01, 2020

BUY
$70.67 - $99.01 $41,412 - $58,019
586 Added 1.32%
44,893 $3.7 Million
Q4 2019

Jan 23, 2020

BUY
$84.35 - $95.37 $307,118 - $347,242
3,641 Added 8.95%
44,307 $4.2 Million
Q3 2019

Oct 31, 2019

BUY
$85.54 - $94.26 $80,749 - $88,981
944 Added 2.38%
40,666 $3.53 Million
Q2 2019

Jul 19, 2019

BUY
$75.4 - $92.8 $28,652 - $35,264
380 Added 0.97%
39,722 $3.63 Million
Q1 2019

Apr 18, 2019

BUY
$75.32 - $86.15 $39,919 - $45,659
530 Added 1.37%
39,342 $3.78 Million
Q4 2018

Jan 31, 2019

BUY
$73.66 - $82.02 $85,445 - $95,143
1,160 Added 3.08%
38,812 $3.33 Million
Q3 2018

Oct 26, 2018

BUY
$66.94 - $77.43 $34,942 - $40,418
522 Added 1.41%
37,652 $3.24 Million
Q2 2018

Jul 27, 2018

BUY
$64.91 - $73.36 $51,084 - $57,734
787 Added 2.17%
37,130 $2.81 Million
Q1 2018

Apr 24, 2018

BUY
$70.39 - $84.15 $21,468 - $25,665
305 Added 0.85%
36,343 $2.94 Million
Q4 2017

Jan 31, 2018

BUY
$72.33 - $77.64 $98,730 - $105,978
1,365 Added 3.94%
36,038 $3.03 Million
Q3 2017

Nov 03, 2017

BUY
$74.14 - $77.27 $2.57 Million - $2.68 Million
34,673
34,673 $2.98 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $229B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Telos Capital Management, Inc. Portfolio

Follow Telos Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telos Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Telos Capital Management, Inc. with notifications on news.